Published in Crit Rev Immunol on January 01, 2009
Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell (2014) 1.58
Epigenetic modifications induced by Blimp-1 Regulate CD8⁺ T cell memory progression during acute virus infection. Immunity (2013) 1.04
Early myeloid dendritic cell dysregulation is predictive of disease progression in simian immunodeficiency virus infection. PLoS Pathog (2010) 0.98
Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog (2011) 0.95
Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice. PLoS One (2011) 0.95
CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis? Pediatr Nephrol (2014) 0.88
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis. Proc Natl Acad Sci U S A (2014) 0.86
Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation. Front Immunol (2015) 0.85
Dissociating markers of senescence and protective ability in memory T cells. PLoS One (2012) 0.84
A proteomic view at T cell costimulation. PLoS One (2012) 0.80
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection. J Infect Dis (2012) 0.80
Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2. Hum Vaccin Immunother (2013) 0.79
The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections. Adv Virol (2011) 0.78
CD28 days later: Resurrecting costimulation for CD8(+) memory T cells. Eur J Immunol (2016) 0.75
Role of STIM2 in cell function and physiopathology. J Physiol (2017) 0.75
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist. Oncologist (2016) 0.75
Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8(+) T-cell differentiation. Immunology (2016) 0.75
CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection. Semin Immunopathol (2015) 0.75
Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 20.00
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med (2000) 19.81
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol (2003) 15.51
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med (2006) 13.15
The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell (2001) 12.59
PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol (2001) 12.26
Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature (2003) 10.16
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Defective CD8 T cell memory following acute infection without CD4 T cell help. Science (2003) 9.67
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med (2006) 8.18
A theory of self-nonself discrimination. Science (1970) 7.99
The B7-CD28 superfamily. Nat Rev Immunol (2002) 7.24
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol (2004) 7.16
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol (2004) 6.80
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity (1995) 5.77
T cell activation determined by T cell receptor number and tunable thresholds. Science (1996) 5.51
ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature (2001) 5.32
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol (2003) 5.01
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol (2001) 4.99
T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol (2001) 4.10
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol (2000) 3.84
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature (2005) 3.81
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med (1992) 3.77
T cell memory. Annu Rev Immunol (2001) 3.70
ICOS is critical for CD40-mediated antibody class switching. Nature (2001) 3.63
Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity (2003) 3.49
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol (2004) 3.49
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity (2003) 3.47
The molecular architecture of the TNF superfamily. Trends Biochem Sci (2002) 3.39
Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J Immunol (2000) 3.34
Dendritic cells maximize the memory CD8 T cell response to infection. Immunity (2005) 3.21
B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity (2003) 3.18
T cell affinity maturation by selective expansion during infection. J Exp Med (1999) 3.08
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity (2001) 3.08
PD-1 and its ligands in T-cell immunity. Curr Opin Immunol (2007) 2.86
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol (1998) 2.74
CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med (2003) 2.62
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood (1995) 2.57
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature (2001) 2.42
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol (2003) 2.22
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J Clin Invest (2008) 2.18
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol (2003) 2.15
Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol (2000) 2.13
Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity (1996) 2.08
The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol (2000) 2.04
Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity (1999) 2.02
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol (2001) 1.96
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med (2002) 1.95
OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity (1999) 1.93
During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J Immunol (2005) 1.81
The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol (1992) 1.79
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood (2000) 1.76
Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J Immunol (2006) 1.73
In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol (2002) 1.70
CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol (1993) 1.63
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol (1999) 1.63
B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat Immunol (2007) 1.61
IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J Immunol (2006) 1.58
Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J Immunol (1999) 1.53
Reactions of the graft versus host (GVH) type. Aust J Exp Biol Med Sci (1969) 1.49
Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol (2000) 1.47
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J Immunol (2004) 1.45
Memory CD8+ T cells require CD28 costimulation. J Immunol (2007) 1.45
Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol (2004) 1.44
Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J Exp Med (1999) 1.42
TNF family ligands define niches for T cell memory. Trends Immunol (2007) 1.38
Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature (1974) 1.37
Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol (1994) 1.36
Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J (2000) 1.35
Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1. J Immunol (2009) 1.34
OX40 drives protective vaccinia virus-specific CD8 T cells. J Immunol (2008) 1.33
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J Immunol (2005) 1.31
B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol (2000) 1.30
A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J Immunol (2004) 1.28
Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. Proc Natl Acad Sci U S A (2004) 1.27
Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors. Cancer Res (2009) 1.26
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. J Immunol (2007) 1.26
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol (2005) 1.25
Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Curr Opin Immunol (2000) 1.25
Costimulation of CD8 T cell responses by OX40. J Immunol (2004) 1.24
Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J Immunol (2008) 1.24
Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. J Immunol (2005) 1.23
Characterization of murine CD70 by molecular cloning and mAb. Int Immunol (1998) 1.23
Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J Immunol (2000) 1.23
ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J Immunol (2008) 1.23
TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells. J Immunol (2006) 1.22
Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol (2008) 1.22
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med (2001) 1.21
4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol (2000) 1.21
OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition. J Immunol (2006) 1.20
Structure and expression of murine CD30 and its role in cytokine production. J Immunol (1996) 1.20
Role of ICOS versus CD28 in antiviral immunity. Eur J Immunol (2002) 1.20
The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol (2005) 1.20
In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol (2002) 1.70
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat Immunol (2013) 1.60
Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med (2002) 1.54
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol (2009) 1.52
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood (2011) 1.52
Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. J Virol (2005) 1.51
Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev (2002) 1.50
Memory CD8+ T cells require CD28 costimulation. J Immunol (2007) 1.45
IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood (2002) 1.43
Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol (2004) 1.36
Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J Immunol (2008) 1.24
Memory T cells need CD28 costimulation to remember. Semin Immunol (2009) 1.22
Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J Immunol (2009) 1.19
Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol (2009) 1.14
HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol (2004) 1.13
The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum (2011) 1.13
IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. Blood (2011) 1.11
Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol (2011) 1.08
Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. PLoS Pathog (2013) 1.04
IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. Int Immunol (2003) 1.03
Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Immunol (2008) 0.96
MicroRNAs: key components of immune regulation. Adv Exp Med Biol (2011) 0.95
Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells. Blood (2006) 0.91
T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention. Int Rev Immunol (2003) 0.91
Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects. J Virol (2007) 0.89
HIV-specific CD8+ T cells: serial killers condemned to die? Curr HIV Res (2004) 0.89
Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1. Antimicrob Agents Chemother (2010) 0.86
Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res Ther (2003) 0.85
CD28 and CD27 costimulation of CD8+ T cells: a story of survival. Adv Exp Med Biol (2007) 0.85
CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads. J Immunol (2009) 0.83
IL-15 in HIV infection: pathogenic or therapeutic potential? Eur Cytokine Netw (2010) 0.83
Neutrophil apoptosis during viral infections. Open Virol J (2009) 0.82
Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology (2014) 0.81
Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus. Vaccine (2010) 0.79
4th Aegean Conference on the Crossroads between Innate and Adaptive Immunity. Nat Immunol (2011) 0.78
Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. Apoptosis (2007) 0.77
A new mechanism of gene regulation mediated by noncoding RNA. J Immunol (2012) 0.76
New insights into classical costimulation of CD8+ T cell responses. Adv Exp Med Biol (2009) 0.75